Juan Granada

Juan Granada

Interventional cardiologist / Cardiologist
Cardiovascular Research Foundation - New York, United States of America

Latest contributions

Mitral hotline: new devices

20 May 2025 – From EuroPCR 2025

Stay updated on emerging devices in mitral valve repair and replacement with this session covering novel technologies including transcatheter edge-to-edge repair (TEER), posterior leaflet restoration, transfemoral mitral annuloplasty, and a first-in-human transseptal TMVR system. Clinical trial data and early feasibility experiences provide valuable insights into advancing...

Mitral hotline: new devices

What is new in atrioventricular valves?

19 May 2025 – From EuroPCR 2025

Discover the latest advancements in atrioventricular valve interventions, including innovative transcatheter repair technologies and first-in-human experiences with novel devices.

What is new in atrioventricular valves?

Voices of innovation: perspectives from the stakeholders

25 Nov 2024 – From PCR London Valves 2024

Curious about how innovation becomes impact? This video is a must-watch! Discover now what drives medical breakthroughs from concept to reality and explore the perspectives of those shaping the future of healthcare.

You’ll gain insights into the challenges innovators face at every stage—breakthrough ideas, market regulation, and...

Voices of innovation: perspectives from the stakeholders

Transcatheter mitral valve replacement - Are we there yet?

25 Nov 2024 – From PCR London Valves 2024

Are we ready to embrace transcatheter mitral valve replacement (TMVR) as the next big step in mitral interventions? Find out in this must-watch video!

Discover the key anatomical factors that favor TMVR over TEER, get acquainted with cutting-edge TMVR platforms like Tioga, Cephea and Intrepid, and master...

Transcatheter mitral valve replacement - Are we there yet?

Electrosurgery and leaflet modification: addressing an unmet need for transcatheter valve interventions

24 Nov 2024 – From PCR London Valves 2024

Electrosurgery and leaflet modification are revolutionizing transcatheter valve interventions, addressing unmet needs for patients who lack conventional treatment options. This video offers a deep dive into the clinical applications of these advanced techniques and equips you with the knowledge to implement them effectively.

You’ll discover:

  • How electrosurgical tools,...
Electrosurgery and leaflet modification: addressing an unmet need for transcatheter valve interventions

Contemporary surgical and transcatheter approaches for multivalve disease

21 Nov 2023 – From PCR London Valves 2023

Explore modern surgical and transcatheter strategies for addressing multivalve disease in this session:  gain in-depth knowledge about the current approaches in both surgical and transcatheter management of multivalve disease, develop a profound understanding of algorithms guiding the identification of the dominant valve lesion and shaping procedural...

Contemporary surgical and transcatheter approaches for multivalve disease

Mitral valve intervention in complex scenarios - Transcatheter mitral valve replacement - who are the eligible patients, and what are the available options?

21 Nov 2023 – From PCR London Valves 2023

This PCR London Valves 2023 session about mitral valve interventions seeks to address three key questions: identifying the ideal patient for Transcatheter Mitral Valve Implantation (TMVI), exploring treatment alternatives for ineligible patients, and discussing the prediction and management of left ventricular outflow tract obstruction. Watch video...

Mitral valve intervention in complex scenarios - Transcatheter mitral valve replacement - who are the eligible patients, and what are the available options?

Transcatheter mitral valve replacement - The wait will be worth it

20 Nov 2023 – From PCR London Valves 2023

Reflect on the past decade of Transcatheter Mitral Valve Replacement (TMVR) to uncover technical and clinical challenges and the lessons they've taught. Explore innovative technologies addressing persistent issues, offering solutions and anticipated timelines. Additionally, delve into the present and future trial designs, exploring the evidence required for...

Transcatheter mitral valve replacement - The wait will be worth it

Tricuspid Late-Breaking Trials: TRISCEND at 2 years, TEER in primary tricuspid regurgitation, TriCLASP, bRIGHT...

19 Nov 2023 – From PCR London Valves 2023

Discover the tricuspid late-breaking trials which were presented during PCR London Valves 2023: 

  • TRISCEND study two-year outcomes: transfemoral TTVR
  • Transcatheter edge-to-edge repair in patients with primary tricuspid regurgitation
  • One-year outcomes of transcatheter tricuspid valve repair from the TriCLASP study
  • TTVR with the LuX-Valve system: one-year outcomes of a multicentre experience
  • Real-world...
Tricuspid Late-Breaking Trials

All you need to know about transcatheter treatment solutions for mitral regurgitation

18 May 2023 – From EuroPCR 2023

Consult this session for a comprehensive understanding of mitral regurgitation including anatomy, pathophysiology, imaging interpretation for diagnosis, intervention selection and procedure guidance, and identifying future unmet needs, illustrated with a series of case examples.

All you need to know about transcatheter treatment solutions for mitral regurgitation

Management of complex non-culprit multivessel disease after STEMI - LIVE case

16 May 2023 – From EuroPCR 2023

Analyze the case of a 69-year-old non-diabetic male patient with mild chronic kidney disease, acute inferior MI and primary PCI on the postero-lateral RCA, whose angiography showed diffuse disease on the proximal CX and second OM (QFR: 0.65), and an intermediate prox LAD lesion (QFR: 0.90).

IVUS...

Management of complex non-culprit MVD after STEMI - LIVE case

Mitral edge-to-edge repair: surgical and transcatheter approaches - LIVE case

29 Nov 2022 – From PCR London Valves 2022

Learn from these 2 cases of primary mitral repair using percutaneous and surgical approaches:

  1. LIVE case - A 90-year-old male with history of LAD PCI 23 years ago and paroxysmal atrial fibrillation presents a primary mitral regurgitation (P2 prolapse) on mildly dilated LV and preserved LV function.
    The operators...
Mitral edge-to-edge repair: surgical and transcatheter approaches

Transcatheter tricuspid valve intervention is booming: where are we now? and where are we going?

29 Nov 2022 – From PCR London Valves 2022

Watch these presentations to better understand what's happening in the field of tricuspid valve intervention and to appreciate the characteristics of current and newly emerging transcatheter devices.

Transcatheter tricuspid valve intervention is booming: where are we now? and where are we going?

Mitral valve-in-valve

18 May 2022 – From EuroPCR 2022

Follow LIVE this case presented by St Thomas' Hospital, London, UK, of a 73-year-old-male patient with a degenerated mitral bioprosthesis to be treated with a catheter-based approach to appreciate key steps in planning and performing transcatheter mitral ViV procedures, and discuss potential approaches to smaller valves...

Mitral valve-in-valve

EuroPCR 2022 Welcome Ceremony

17 May 2022 – From EuroPCR 2022

It is with emotion that William Wijns and Jean Fajadet opened this new edition of EuroPCR, which introduced a hybrid format, combining on-site and online learning. "Spark" is the key word for this EuroPCR 2022, which aims to put the spotlight on nurses and allied professionals,...

EuroPCR 2022 Welcome Ceremony

Long LAD lesion treated by Robotic PCI - Session with LIVE case

17 May 2022 – From EuroPCR 2022

Learn more about this active 65-year-old patient with previous TIA, de novo angina, hypertension, normal cognitive functions, and physical examination who will be treated live from Toulouse, France in this session!

EuroPCR 2022 Early experience and registry results in TAVI: Optimize PRO, FORWARD PRO, Neo-Align, and more!

17 May 2022 – From EuroPCR 2022

Find out more about various studies & registries in TAVI! ACURATE neo2 post-procedural hemodynamic outcomes, first real-world results of the JenaValve TAVI system, Optimize PRO study, a next-generation aortic transcatheter heart valve, commissural alignment, and three-year outcomes following TAVI with a self-expanding valve with pericardial wrap.

EuroPCR 2022 Hotlines / Late-Breaking Trials in TAVI: Optimize PRO, FORWARD PRO, Neo-Align, and more!

Transcatheter tricuspid valve interventions: the future

23 Nov 2021 – From PCR London Valves 2021

In this PCR London Valves 2021 session, observe the case of an 84-year-old, not overweight, quite active, female patient with a past history of restrictive cardiomyopathy and permanent atrial fibrillation, who presented with worsening dyspnea and obvious clinical signs of right ventricular heart failure, and discuss the...

Transcatheter tricuspid valve interventions: the future

TAVI: the future

22 Nov 2021 – From PCR London Valves 2021

This session from PCR London Valves 2021 particularly focuses on the expected expansions of TAVI to patients at a younger age and with a longer life expectancy, including a virtual live case from Clinique Pasteur, Toulouse, France.

TAVI: the future

Transcatheter mitral interventions: the future

21 Nov 2021 – From PCR London Valves 2021

What could be the future of transcatheter mitral valve intervention? Will it be repair or replacement? What are the current limitations? Find parts of the answers to these questions, and many others, in this session shot during the PCR LV 2021 Congress.

Transcatheter mitral interventions: the future

Innovations in surgical and transcatheter tricuspid valve intervention

24 Nov 2020 – From PCR Valves e-Course 2020

Watch this session if you want to hear more about the latest advances in surgical and transcatheter approaches to tricuspid valve disease, to appreciate the anatomical, clinical and engineering challenges associated with future development and to learn how the COVID 19 pandemic has impacted on progress...

PCR Planet: interventional cardiology in the context of COVID-19 in Argentina and the USA

28 May 2020

A. Ferrero, Argentina, and J. Granada, USA, discuss the challenges of practising cardiology in the context of the COVID-19 pandemic with B. Prendergast.

PCR and CRF Announce Partners in Learning Virtual Sessions

28 May 2020

NEW YORK – PCR and CRF are pleased to announce the creation of virtual Partners in Learning sessions that will be broadcast during the PCR e-Course (June 25-27, 2020 - #PCReCourse) and CRF’s TVT Connect meeting (June 18-28, 2020). The sessions, which will cover coronary artery...

PCR and TCT announce the creation of a New Educational Program: Partners in Learning

21 Jan 2020

New York, NY – Tuesday 21, 2020 – PCR and TCT are proud to announce the creation of a new educational program: “Partners in Learning”. The first of its kind will focus on TAVI practitioners, taking place on 21-22 March 2020 in Sao Paulo, Brazil. It...

LIVE demonstration from National University Heart Centre Singapore: Image-guided multivessel PCI

23 May 2019 – From EuroPCR 2019

Watch this LIVE demonstration from National University Heart Centre (Singapore) to discover the case of a 56 years-old male admitted for NSTEMI and paroxysmal AFib, whose angiogram also revealed a LAD/RCA disease. He was planned for a multivessel PCI: watch the treatment now!

Innovative First-in-Man trials and early phase studies

22 May 2019 – From EuroPCR 2019

Consult this session to learn more about innovative First-in-Man trials and early phase studies regarding hypertension, chronic heart failure and renal denervation, such as: TROPHY1, Cryo-RDN, AFR-Prelieve, and more!

Innovative First-in-Man trials and early phase studies

Trials and registries - Long term clinical outcomes after TAVI

21 May 2019 – From EuroPCR 2019

Consult this session to learn about the latest trials and registries regarding the long term clinical outcomes after TAVI, such as CHOICE, INTeNSE, RASTAVI, and more!

Acute/chronic heart failure: new interventional options

21 May 2019 – From EuroPCR 2019

Consult this session on acute/chronic heart failure to discover new interventional options, such as an implantable left-sided pressure sensor for monitoring patients, a cardiac autonomic nerves stimulation to improve haemodynamics and clinical status, the PROPELLA concept, and more!

Acute/chronic heart failure: new interventional options

Sticky problems, new solutions

20 May 2019 – From PCR Innovators Day 2019

Consult this session on "Sticky problems, new solutions" to discover the studies and tools developed by Cavis Technologies, Wirecath, CorFlow Therapeutics, Procyrion and GENOSS, and learn more about how to "unstick" from the problems you usually encounter during your practice.